Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
ANTI-NLS SCFV AND PEPTIDES AND USES THEREOF IN NUCLEAR IMPORT INHIBITION
Document Type and Number:
WIPO Patent Application WO2003089472
Kind Code:
A3
Abstract:
The present invention relates to a substance that specifically binds a nuclear localization signal (NLS)-containing molecule. Said substance may be a naturally occurring, synthetic or recombinant antibody, or it may be a protein, a peptide or a small molecule. Preferably, said NLS-containing molecule is a HIV-1 protein, more preferably Vpr or Tat. In addition, the present invention relates to a composition or a vaccine comprising the substance of the invention, as well as methods of inhibiting viral infection through the administration thereof.

Inventors:
LOYTER ABRAHAM (IL)
GRAESSMAN ADOLF (DE)
NISSIM AHUVA (IL)
KRICHEVSKY ALEXANDER (IL)
ZAKAI NECHAMA (IL)
Application Number:
PCT/IL2003/000328
Publication Date:
May 13, 2004
Filing Date:
April 21, 2003
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
YISSUM RES DEV CO (IL)
LOYTER ABRAHAM (IL)
GRAESSMAN ADOLF (DE)
NISSIM AHUVA (IL)
KRICHEVSKY ALEXANDER (IL)
ZAKAI NECHAMA (IL)
International Classes:
A61P31/18; C07K16/10; A61K38/00; (IPC1-7): C07K16/10; A61K39/42; A61K38/16; C07K14/005; A61P31/18
Domestic Patent References:
WO1999028338A11999-06-10
WO2000049038A22000-08-24
Other References:
DUBROVSKY LARISA ET AL: "Nuclear localization signal of HIV-1 as a novel target for therapeutic intervention.", MOLECULAR MEDICINE (CAMBRIDGE), vol. 1, no. 2, 1995, pages 217 - 230, XP008021708, ISSN: 1076-1551
KARNI O ET AL: "A peptide derived from the N-terminal region of HIV-1 Vpr promotes nuclear import in permeabilized cells: elucidation of the NLS region of the Vpr", FEBS LETTERS, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 429, no. 3, 16 June 1998 (1998-06-16), pages 421 - 425, XP004258047, ISSN: 0014-5793
Download PDF: